Clinical Trial Update: A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

Phase 2 study assessing efficacy and safety of Filgotinib in Ankylosing Spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Galapagos NV | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED